R K Dhingra
Overview
Explore the profile of R K Dhingra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agarwal A, Silver M, Reed J, Dhingra R, Liu W, Varma N, et al.
J Intern Med
. 2006 Nov;
260(6):577-85.
PMID: 17116009
Objective: To demonstrate the efficacy and safety of once-monthly (QM) darbepoetin alfa administration in maintaining haemoglobin (Hb) 11.0-13.0 g dL(-1) in subjects with chronic kidney disease (CKD) not receiving dialysis...
2.
Gradzki R, Dhingra R, Port F, Roys E, Weitzel W, Messana J
Am J Kidney Dis
. 2001 Dec;
38(6):1240-4.
PMID: 11728956
Vascular access complications are common in hemodialysis patients. To investigate whether the use of angiotensin-converting enzyme (ACE) inhibitors influences the rate of polytetrafluoroethylene (PTFE) graft complications, we compared the rate...
3.
Weitzel W, Rubin J, Leavey S, Swartz R, Dhingra R, Messana J
Am J Kidney Dis
. 2001 Oct;
38(5):935-40.
PMID: 11684544
The variable flow (VF) Doppler method determines access blood flow from the pump speed-induced change in Doppler signal between the arterial and venous needles. This study evaluated 35 patients in...
4.
Dhingra R, Young E, Leavey S, Port F
Kidney Int
. 2001 Sep;
60(4):1443-51.
PMID: 11576358
Background: Vascular access (VA) complications account for 16 to 25% of hospital admissions. This study tested the hypothesis that the type of VA in use is correlated with overall mortality...
5.
Dhingra R, Sprague S, Ojo A, Leavey S
Transplantation
. 2001 Jul;
71(12):1856-9.
PMID: 11455270
Although bisphosponates are proposed as first-line treatment for posttransplant bone disease they are not optimal in all situations. A kidney transplant recipient developed hypercalcemia from mobilization of extraskeletal calcium. He...
6.
Dhingra R, Williams Jr R, REED W
Infect Immun
. 1977 Jan;
15(1):169-74.
PMID: 13039
Pneumoccal cell wall and capsular products from eight serotypes were tested for their ability to inhibit polymorphonuclear neutrophil killing of the same eight pneumococcal strains. Crude pneumococcal cell wall preparations...
7.
Chugh T, Dhingra R, Gulati R, Bathla J
Indian J Med Res
. 1973 Aug;
61(8):1147-52.
PMID: 4761285
No abstract available.
8.
Chugh T, Dhingra R, Gulati R, Bathla J
Indian J Med Res
. 1973 Jul;
61(7):998-1001.
PMID: 4758005
No abstract available.